Results 171 to 180 of about 27,119 (268)

Strengths, limitations, and way forward of home-based rehabilitation practices after stroke: a scoping review. [PDF]

BMC Health Serv Res
Oppici L, Hestetun-Mandrup AM, Pacheco MM, Simonsen EH, Opheim A, Rafsten L, Løvstad M, Bērziņa G, Sunnerhagen KS, Rudd JR.   +9 more
europepmc   +1 more source

Effect of individualized nutrition management strategy combined with continuous care model on the nutritional status and quality of life in patients with liver cirrhosis

Huli yanjiu, 2023
DU Xufang, LI Chao, WANG Peng, YAO Jia, YANG Liuqing, HOU Huimin   +5 more
doaj  

Essential Updates 2024–2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization

Annals of Gastroenterological Surgery, EarlyView.
This review summarizes key advances from 2024 to 2025 that are reshaping esophageal cancer surgery toward a strategy‐oriented, personalized paradigm through the integration of immunotherapy, population aging, and intelligent technologies. Adjuvant nivolumab after neoadjuvant chemoradiotherapy remains the only perioperative approach with durable benefit,
Shuichiro Oya, Koichi Yagi, Yoshifumi Baba   +2 more
wiley   +1 more source

Artificial intelligence for improving decision-making in bacterial infection management: a narrative review. [PDF]

J Antimicrob Chemother
Talianu A, Fraser-Krauss O, Bolton W, Ming D, Zhu N, Hernandez B, Gilchrist M, Holmes A, Georgiou P, Rawson TM.   +9 more
europepmc   +1 more source

Potential Survival Benefit of Neoadjuvant Docetaxel, Cisplatin and 5‐Fluorouracil Therapy in Patients With Esophageal Squamous Cell Carcinoma With Multiple Lymph Node Metastases: A Single‐Institute Propensity Score Analysis

Annals of Gastroenterological Surgery, EarlyView.
Although neoadjuvant chemotherapy with fluorouracil, cisplatin, and docetaxel (NAC‐DCF) is the current standard neoadjuvant regimen for esophageal squamous cell carcinoma, its substantial toxicity underscores the need to identify patients who derive the greatest benefit.
Eiji Higaki, Tetsuya Abe, Hironori Fujieda, Shigenori Kadowaki, Tsutomu Tanaka, Masahiro Tajika, Koji Komori, Seiji Ito, Isao Oze, Kei Muro   +9 more
wiley   +1 more source

Response to the Letter to the Editor Entitled "Beyond Lymphocytic Inflammation: Immune Architecture as a Determinant of Renal Outcomes". [PDF]

Kidney Int Rep
Boudhabhay I, Isnard P.
europepmc   +1 more source

Prevalence of MSI‐H/dMMR Colorectal Cancer in Japan: Data From the Clinical Study Group of the University of Osaka‐Colorectal Registry

Annals of Gastroenterological Surgery, EarlyView.
Using a multicenter Japanese colorectal cancer cohort from 25 institutions, we analyzed 1464 patients across all disease stages and tumor locations to determine the prevalence and clinicopathological features of MSI‐H/dMMR colorectal cancer. MSI‐H/dMMR tumors accounted for 9.4% of cases overall, were present in 22% of right‐sided colon cancers, and ...
Yoshihiro Morimoto, Mamoru Uemura, Yoshinori Kagawa, Hidekazu Takahashi, Masayuki Hiraki, Yozo Suzuki, Shinichi Yoshioka, Mitsuyoshi Tei, Shu Okamura, Yukako Mokutani, Atsushi Naito, Shinji Tokuyama, Takamichi Komori, Akinobu Yasuyama, Genta Sawada, Yujiro Fujie, Shinya Yamashita, Naotsugu Haraguchi, Yusuke Matsuura, Chu Matsuda, Yoshinao Chinen, Tatsushi Shingai, Katsuki Danno, Nobuo Tanaka, Kazuya Sakata, Kohei Murata, Yuichiro Doki, Hidetoshi Eguchi   +27 more
wiley   +1 more source

New neurons flatten social hierarchies. [PDF]

Sci Rep
Doludda B, Franz M, Bogado Lopes J, Overall RW, Rünker AE, Croy I, Kempermann G.   +6 more
europepmc   +1 more source

Innovations in Gastric Cancer Surgery During Early Minimally Invasive Era and Future Perspectives

Annals of Gastroenterological Surgery, EarlyView.
With continuing revelations in tumor biology and the emergence of artificial intelligence, new horizons for surgical innovation are opening. At the center of this transformative journey stands the innovative surgeon, driven by passion, guided by data, and steadfast in the commitment to patient safety and quality of life.
Reut El‐On, Young‐Woo Kim
wiley   +1 more source

Sorting out and navigating uncertainty in precision medicine. [PDF]

Hist Philos Life Sci
Borck C, Lohse S.
europepmc   +1 more source